Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
32,773,554
-
Share change
-
+2,708,247
-
Total reported value
-
$1,185,318,197
-
Put/Call ratio
-
126%
-
Price per share
-
$36.19
-
Number of holders
-
136
-
Value change
-
+$99,254,466
-
Number of buys
-
59
-
Number of sells
-
59
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q3 2016
As of 30 Sep 2016,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,773,554 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Polaris Venture Management Co IV LLC, OAK RIDGE INVESTMENTS LLC, BlackRock Fund Advisors, Novo A/S, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
136
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.